130 Results

People

  1. Sadelain
    Sadelain
  2. Chiosis
    Chiosis
  3. Thompson
    Thompson
  4. Lesokhin
    Lesokhin
  5. Scheinberg
    Scheinberg
  6. Brentjens
    Brentjens
  7. Giralt
    Giralt
  8. Sun
    Sun
  9. Taldone
    Taldone
  10. Riviere
    Riviere

Groups

  1. Center for Hematologic Malignancies (130)
  2. Hematologic Malignancies Research (130)
  3. GSK Faculty (123)
  4. Sloan Kettering Institute Faculty (110)
  5. Department of Medicine (80)
  6. Molecular Pharmacology and Chemistry Program Faculty (76)
  7. Hematologic Malignancies, Division of (73)
  8. Sloan Kettering Institute Postdocs (35)
  9. Adult Leukemia (28)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (26)
  1. "Hematologic Malignancies Research"
  2. "2013"
Formats
  1. Journal Article (72)
  2. Meeting Abstract (57)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (130)
  2. Hematologic Malignancies Research (130)
  3. GSK Faculty (123)
  4. Sloan Kettering Institute Faculty (110)
  5. Department of Medicine (80)
  6. Molecular Pharmacology and Chemistry Program Faculty (76)

More Groups

People
  1. Michel Sadelain (33)
  2. Gabriela Chiosis (21)
  3. Craig Thompson (17)
  4. Alexander Lesokhin (13)
  5. Isabelle Riviere (13)
  6. David Scheinberg (12)

More People

Years
  1. 2013 (130)
Publications
  1. Blood (22)
  2. Journal of Clinical Oncology (8)
  3. Journal of Immunology (7)
  4. Journal of Thoracic Oncology (5)
  5. Molecular Therapy (5)
  6. Biology of Blood and Marrow Transplantation (4)

More Publications

Publishers
  1. American Society of Hematology (22)
  2. Nature Publishing Group (15)
  3. Elsevier Inc. (14)
  4. American Society of Clinical Oncology (8)
  5. The American Association of Immunologists, Inc (7)
  6. American Association for Cancer Research (6)

More Publishers

Results (130)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Reed, K.; Burke, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I dose-escalation study evaluating the effects of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with select relapsed or refractory hematologic malignancies
    Meeting Abstract

    Lesokhin, A. M.; Gutierrez, M.; Halwani, A. S.; Ansell, S. M.; Armand, P.; Borrello, I.; Segota, Z. E.; Cohen, A. D.; Talpaz, M.; Cattry, D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL
    Meeting Abstract

    Dubrovsky, L.; Brea, E. J.; Veomett, N. J.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Peripheral and tumor immune correlates in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
    Meeting Abstract

    Callahan, M. K.; Horak, C. E.; Curran, M. A.; Hollman, T.; Schaer, D. A.; Yuan, J.; Lesokhin, A. M.; Kitano, S.; Hong, Q.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models
    Meeting Abstract

    Ambati, S. R.; Lopes, E. C.; Kosugi, K.; Mony, U.; Zehir, A.; Moreira, A. L.; Meyers, P. A.; Chiosis, G.; Moore, M. A. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Arginine methylation of RBM15 by PRMT1 controls alternative splicing of genes involved in megakaryocyte differentiation
    Meeting Abstract

    Zhao, X.; Zhang, L.; Wang, R.; Trans, N. T.; Su, H.; Abdel-Wahab, O.; Hrick, T.; Levine, R. L.; Deng, H.; Liu, Y.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Influence of killer immunoglobulin-like receptor (KIR) and HLA genotypes on outcomes after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for patients with AML and MDS: A report from the Center For International Blood and Marrow Transplant Research Immunobiology Working Committee
    Meeting Abstract

    Sobecks, R. M.; Gallagher, M. M.; Askar, M.; Haagenson, M. D.; Wang, T.; Spellman, S.; Lee, S. J.; Fernandez Viña, M. A.; Muller, C. R.; Verneris, M. R.; more...
    Blood (2013)

    Fulltext@MSK | Save